JointPlan News

th

Stem Cell Therapy

The International Society for Stem Cell Research has issued a statement that “When a professional consensus on the safety and therapeutic value of a treatment is lacking, the ISSCR believes it is unethical and unprofessional to market such interventions directly to patients”. The COA supports this statement.
COF-logo

Ortholink Newsletter

OrthoLink is the Foundation’s newsletter, written for people interested in building and keeping their bone and joint health.